Humana Inc (HUM)
NYSE:HUM
Want to see HUM full AI Analyst Report?
HUM Stock Chart & Stats
$205.14
$0.14(0.05%)
At close: 4:00 PM EST
$205.14
$0.14(0.05%)
Day’s Range― - ―
52-Week Range$163.11 - $315.35
Previous CloseN/A
Volume197.44K
Average Volume (3M)1.68M
Market Cap
$28.05B
Enterprise Value$37.09B
Total Cash (Recent Filing)$21.96B
Total Debt (Recent Filing)$13.99B
Price to Earnings (P/E)4.4
Beta0.91
Next Earnings
Aug 05, 2026EPS Estimate
6.42Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)10.31
Shares Outstanding120,061,500
10 Day Avg. Volume1,970,378
30 Day Avg. Volume1,677,647
Financial Highlights & Ratios
PEG Ratio-18.57
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market Cap1.32
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit1.93
Enterprise Value/Ebitda13.01
Forecast
1Y Price Target
$230.21Price Target Upside12.22% Upside
Rating ConsensusHold
Number of Analyst Covering20
EPS Forecast (FY)8.93
Revenue Forecast (FY)$162.44B
Bulls Say, Bears Say
Bulls Say
Membership Quality And RetentionAnalyst highlights improved member retention and a sales mix favoring returning and voluntary switchers, which should lower medical loss ratios and support margin expansion as Humana shifts away from loss‑leader plans.
Quality Ratings UpsideAnalyst believes Humana is positioned to regain top‑quartile Star Ratings, which would improve plan reimbursements and provide clear upside to earnings estimates.
Strategic AcquisitionAnalyst notes that Humana's acquisition of MaxHealth expands value-based primary and specialty care capacity and strengthens the company's Medicare Advantage presence in Florida, supporting growth in managed-care revenue.
Bears Say
Benefit Generosity And Margin PressureAnalyst's actuarial analysis indicates Humana's adjusted value‑add benefits are richer than peers, creating comparative margin pressure if pricing cannot offset higher benefit costs.
Medical Loss Ratio Risk From GrowthAnalyst warns that rapid Medicare Advantage membership growth may attract higher‑cost members and increase medical loss ratios, risking lower adjusted earnings versus company guidance.
Regulatory And Rating UncertaintyAnalyst notes regulatory inputs and uncertainty around star‑rating thresholds create a policy overhang that could delay margin recovery and hinder profitability improvement.
Humana News
HUM FAQ
What was Humana Inc’s price range in the past 12 months?
Humana Inc lowest stock price was $163.11 and its highest was $315.35 in the past 12 months.
What is Humana Inc’s market cap?
Humana Inc’s market cap is $28.05B.
When is Humana Inc’s upcoming earnings report date?
Humana Inc’s upcoming earnings report date is Aug 05, 2026 which is in 93 days.
How were Humana Inc’s earnings last quarter?
Humana Inc released its earnings results on Apr 29, 2026. The company reported $10.31 earnings per share for the quarter, beating the consensus estimate of $10.245 by $0.065.
Is Humana Inc overvalued?
According to Wall Street analysts Humana Inc’s price is currently Undervalued.
Does Humana Inc pay dividends?
Humana Inc pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 1.38%. See more information on Humana Inc dividends here
What is Humana Inc’s EPS estimate?
Humana Inc’s EPS estimate is 6.42.
How many shares outstanding does Humana Inc have?
Humana Inc has 120,061,500 shares outstanding.
What happened to Humana Inc’s price movement after its last earnings report?
Humana Inc reported an EPS of $10.31 in its last earnings report, beating expectations of $10.245. Following the earnings report the stock price went up 5.833%.
Which hedge fund is a major shareholder of Humana Inc?
Currently, no hedge funds are holding shares in HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$230.21 (12.22% Upside)
$230.21 (12.22% Upside)
Blogger Sentiment
Bullish
HUM Sentiment 60%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 305.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.21%
12-Months-Change
Fundamentals
Return on Equity
6.19%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
Humana Inc
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
HUM Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed constructive progress on strategic priorities — membership growth, CenterWell expansion, balance sheet improvements, operational transformation, and measured Stars progress — while candidly acknowledging persistent headwinds: medical cost trend outpacing funding, elevated early-year reserves, potential put-option cash exposure, and the need to consider benefit adjustments in 2027. Management emphasized prudence in reserving, disciplined bidding, and multiple levers (operational improvements, M&A, pricing) to meet the 2028 margin objective.View all HUM earnings summariesHUM Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income
HUM Stock 12 Month Forecast
Average Price Target
$230.21
▲(12.22% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
37.80% Mutual Funds
5.99% Other Institutional Investors
27.89% Public Companies and Individual Investors